Abbott LaboratoriesABTNYSE
Loading
Book Value/Share Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR-1.9%
5Y CAGR-7.5%
Year-over-Year Change
Year-over-year book value per share growth
3Y CAGR
-1.9%/yr
vs +101.6%/yr prior
5Y CAGR
-7.5%/yr
Recent acceleration
Acceleration
-103.6pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 3.06% |
| Q3 2025 | 0.36% |
| Q2 2025 | 4.00% |
| Q1 2025 | 1.52% |
| Q4 2024 | 19.86% |
| Q3 2024 | 1.16% |
| Q2 2024 | 1.32% |
| Q1 2024 | 0.56% |
| Q4 2023 | 3.28% |
| Q3 2023 | 0.87% |
| Q2 2023 | 0.54% |
| Q1 2023 | 0.66% |
| Q4 2022 | 3.24% |
| Q3 2022 | -1.89% |
| Q2 2022 | 3.03% |
| Q1 2022 | -0.35% |
| Q4 2021 | 4.25% |
| Q3 2021 | 2.05% |
| Q2 2021 | 0.94% |
| Q1 2021 | 2.06% |
| Q4 2020 | 4.52% |
| Q3 2020 | 2.48% |
| Q2 2020 | 1.12% |
| Q1 2020 | -3.14% |
| Q4 2019 | -1.91% |
| Q3 2019 | 0.33% |
| Q2 2019 | 2.27% |
| Q1 2019 | 0.83% |
| Q4 2018 | -0.53% |
| Q3 2018 | 0.29% |
| Q2 2018 | -2.68% |
| Q1 2018 | 1.06% |
| Q4 2017 | -3.64% |
| Q3 2017 | 1.17% |
| Q2 2017 | 0.64% |
| Q1 2017 | 16.11% |
| Q4 2016 | 10.32% |
| Q3 2016 | 0.33% |
| Q2 2016 | -0.28% |
| Q1 2016 | -2.04% |